Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Multiplexed FluoroSpot for the Analysis of Dengue Virus- and Zika Virus-Specific and Cross-Reactive Memory B Cells.

Adam A, Woda M, Kounlavouth S, Rothman AL, Jarman RG, Cox JH, Ledgerwood JE, Gromowski GD, Currier JR, Friberg H, Mathew A.

J Immunol. 2018 Dec 15;201(12):3804-3814. doi: 10.4049/jimmunol.1800892. Epub 2018 Nov 9.

PMID:
30413671
2.

Decreased accumulation of subgenomic RNA in human cells infected with vaccine candidate DEN4Δ30 increases viral susceptibility to type I interferon.

Bustos-Arriaga J, Gromowski GD, Tsetsarkin KA, Firestone CY, Castro-Jiménez T, Pletnev AG, Cedillo-Barrón L, Whitehead SS.

Vaccine. 2018 Jun 7;36(24):3460-3467. doi: 10.1016/j.vaccine.2018.04.087. Epub 2018 May 8.

PMID:
29752023
3.

Delineating the serotype-specific neutralizing antibody response to a live attenuated tetravalent dengue vaccine.

Gromowski GD, Henein S, Kannadka CB, Barvir DA, Thomas SJ, de Silva AM, Jarman RG.

Vaccine. 2018 Apr 25;36(18):2403-2410. doi: 10.1016/j.vaccine.2018.03.055. Epub 2018 Mar 27.

PMID:
29602701
4.

African and Asian Zika Virus Isolates Display Phenotypic Differences Both In Vitro and In Vivo.

Smith DR, Sprague TR, Hollidge BS, Valdez SM, Padilla SL, Bellanca SA, Golden JW, Coyne SR, Kulesh DA, Miller LJ, Haddow AD, Koehler JW, Gromowski GD, Jarman RG, Alera MTP, Yoon IK, Buathong R, Lowen RG, Kane CD, Minogue TD, Bavari S, Tesh RB, Weaver SC, Linthicum KJ, Pitt ML, Nasar F.

Am J Trop Med Hyg. 2018 Feb;98(2):432-444. doi: 10.4269/ajtmh.17-0685. Epub 2017 Dec 21.

5.

Durability and correlates of vaccine protection against Zika virus in rhesus monkeys.

Abbink P, Larocca RA, Visitsunthorn K, Boyd M, De La Barrera RA, Gromowski GD, Kirilova M, Peterson R, Li Z, Nanayakkara O, Nityanandam R, Mercado NB, Borducchi EN, Chandrashekar A, Jetton D, Mojta S, Gandhi P, LeSuer J, Khatiwada S, Lewis MG, Modjarrad K, Jarman RG, Eckels KH, Thomas SJ, Michael NL, Barouch DH.

Sci Transl Med. 2017 Dec 13;9(420). pii: eaao4163. doi: 10.1126/scitranslmed.aao4163. Erratum in: Sci Transl Med. 2018 Jul 18;10(450):.

6.

Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques.

McCracken MK, Gromowski GD, Friberg HL, Lin X, Abbink P, De La Barrera R, Eckles KH, Garver LS, Boyd M, Jetton D, Barouch DH, Wise MC, Lewis BS, Currier JR, Modjarrad K, Milazzo M, Liu M, Mullins AB, Putnak JR, Michael NL, Jarman RG, Thomas SJ.

PLoS Pathog. 2017 Aug 3;13(8):e1006487. doi: 10.1371/journal.ppat.1006487. eCollection 2017 Aug.

7.

A DENV-2-type-specific monoclonal antibody binds to the DENV-complex-reactive antigenic site on envelope protein domain 3.

Sarathy VV, Pitcher TJ, Gromowski GD, Roehrig JT, Barrett ADT.

J Gen Virol. 2017 Jun;98(6):1299-1304. doi: 10.1099/jgv.0.000785. Epub 2017 Jun 20.

PMID:
28631593
8.

Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.

Chaudhury S, Gromowski GD, Ripoll DR, Khavrutskii IV, Desai V, Wallqvist A.

PLoS Negl Trop Dis. 2017 Feb 21;11(2):e0005395. doi: 10.1371/journal.pntd.0005395. eCollection 2017 Feb.

9.

Dengue viruses cluster antigenically but not as discrete serotypes.

Katzelnick LC, Fonville JM, Gromowski GD, Bustos Arriaga J, Green A, James SL, Lau L, Montoya M, Wang C, VanBlargan LA, Russell CA, Thu HM, Pierson TC, Buchy P, Aaskov JG, Muñoz-Jordán JL, Vasilakis N, Gibbons RV, Tesh RB, Osterhaus AD, Fouchier RA, Durbin A, Simmons CP, Holmes EC, Harris E, Whitehead SS, Smith DJ.

Science. 2015 Sep 18;349(6254):1338-43. doi: 10.1126/science.aac5017.

10.

Soluble mediators produced by the crosstalk between microvascular endothelial cells and dengue-infected primary dermal fibroblasts inhibit dengue virus replication and increase leukocyte transmigration.

Bustos-Arriaga J, Mita-Mendoza NK, Lopez-Gonzalez M, García-Cordero J, Juárez-Delgado FJ, Gromowski GD, Méndez-Cruz RA, Fairhurst RM, Whitehead SS, Cedillo-Barrón L.

Immunol Res. 2016 Apr;64(2):392-403. doi: 10.1007/s12026-015-8675-8.

PMID:
26130295
11.

Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice.

Gromowski GD, Firestone CY, Whitehead SS.

J Virol. 2015 Jun;89(12):6328-37. doi: 10.1128/JVI.00219-15. Epub 2015 Apr 8.

12.

Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues.

Pitcher TJ, Sarathy VV, Matsui K, Gromowski GD, Huang CY, Barrett AD.

J Gen Virol. 2015 Feb;96(Pt 2):288-93. doi: 10.1099/vir.0.070813-0. Epub 2014 Oct 22.

13.

Genetic and phenotypic properties of vero cell-adapted Japanese encephalitis virus SA14-14-2 vaccine strain variants and a recombinant clone, which demonstrates attenuation and immunogenicity in mice.

Gromowski GD, Firestone CY, Bustos-Arriaga J, Whitehead SS.

Am J Trop Med Hyg. 2015 Jan;92(1):98-107. doi: 10.4269/ajtmh.14-0427. Epub 2014 Oct 13.

14.

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Gromowski GD, Firestone CY, Hanson CT, Whitehead SS.

Vaccine. 2014 May 23;32(25):3010-8. doi: 10.1016/j.vaccine.2014.03.062. Epub 2014 Mar 31.

15.

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes.

Pitcher TJ, Gromowski GD, Beasley DW, Barrett AD.

Virology. 2012 Jan 20;422(2):386-92. doi: 10.1016/j.virol.2011.10.020. Epub 2011 Dec 5.

16.

Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.

Gromowski GD, Roehrig JT, Diamond MS, Lee JC, Pitcher TJ, Barrett AD.

Virology. 2010 Nov 25;407(2):237-46. doi: 10.1016/j.virol.2010.06.044. Epub 2010 Sep 15.

17.

Role of BC loop residues in structure, function and antigenicity of the West Nile virus envelope protein receptor-binding domain III.

Zhang S, Bovshik EI, Maillard R, Gromowski GD, Volk DE, Schein CH, Huang CY, Gorenstein DG, Lee JC, Barrett AD, Beasley DW.

Virology. 2010 Jul 20;403(1):85-91. doi: 10.1016/j.virol.2010.03.038. Epub 2010 May 6.

18.

Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III.

Matsui K, Gromowski GD, Li L, Barrett AD.

J Gen Virol. 2010 Sep;91(Pt 9):2249-53. doi: 10.1099/vir.0.021220-0. Epub 2010 May 5.

19.

Characterization of dengue complex-reactive epitopes on dengue 3 virus envelope protein domain III.

Matsui K, Gromowski GD, Li L, Schuh AJ, Lee JC, Barrett AD.

Virology. 2009 Feb 5;384(1):16-20. doi: 10.1016/j.virol.2008.11.013. Epub 2008 Dec 19.

20.

Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus.

Gromowski GD, Barrett ND, Barrett AD.

J Virol. 2008 Sep;82(17):8828-37. doi: 10.1128/JVI.00606-08. Epub 2008 Jun 18.

21.

Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.

Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS.

J Virol. 2007 Dec;81(23):12816-26. Epub 2007 Sep 19.

23.

Solution structure of the envelope protein domain III of dengue-4 virus.

Volk DE, Lee YC, Li X, Thiviyanathan V, Gromowski GD, Li L, Lamb AR, Beasley DW, Barrett AD, Gorenstein DG.

Virology. 2007 Jul 20;364(1):147-54. Epub 2007 Mar 29.

24.

Venezuelan equine encephalitis virus transmission and effect on pathogenesis.

Smith DR, Aguilar PV, Coffey LL, Gromowski GD, Wang E, Weaver SC.

Emerg Infect Dis. 2006 Aug;12(8):1190-6.

25.

Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains.

Beasley DW, Whiteman MC, Zhang S, Huang CY, Schneider BS, Smith DR, Gromowski GD, Higgs S, Kinney RM, Barrett AD.

J Virol. 2005 Jul;79(13):8339-47.

Supplemental Content

Loading ...
Support Center